trial

Clinical Evaluation of Acupuncture Treatment for Negative Symptoms of Schizophrenia

NCTId NCT03802838
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Unknown
Enrollment 50 (estimated)
Sponsored by Shanghai Mental Health Center
Primary completion 2019-04-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Unknown
Enrollment
50 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2017-10-01
Primary completion
2019-04-01
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
acupunctureAmisulpride

Sponsors

Shanghai Mental Health CenterLead Sponsor

Investigators

1
Zhenghui YiPrincipal Investigator

Sites

1 total
Shanghai, China

Facts & assertions

4 sourced
Enrollment
50
Phase
PHASE4
Primary Completion Date
2019-04-01
Status
UNKNOWN
relationships
The graph out of here
drug
acupuncture
drug
Amisulpride
drug
lead_sponsor
Shanghai Mental Health Center
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Zhenghui Yi
person